Why TFX Stock advanced +0.64% Today — RQD Quant Desk Flash

TFX scores 48 out of 100, a grade of D, with the verdict "Roarable Sell — Underperform / Distribution Warning." The Fundamental Cash Engine pillar scores 6 out of 20, reflecting ROIC of 1.8% and an FCF yield of -18%; this is the weakest pillar and indicates the business is not currently generating attractive returns on invested capital or positive free cash flow. The Whale 13F Flow pillar scores 17 out of 20, the strongest pillar, reflecting institutional accumulation and options positioning. Insider Conviction scores 5 out of 20, reflecting SEC Form 4 and Congressional PTR cluster flow that the rating characterizes as weak. Macro Regime Fit scores 11 out of 20, with a Beta of 0.98 and a sector sensitivity profile. Forensic Balance Sheet scores 9 out of 20, reflecting an Altman Z of 2.12, a Piotroski F of 4 out of 9, and Debt/Equity of 0.81.

For a prospective investor, the upside case rests mainly on the institutional positioning signal, which is the only pillar near the top of its range. The valuation tradeoff is significant: per the market data, forward P/E is 27 and EV/EBITDA is 40.9 against trailing EPS of -21.37, so the price embeds expectations that the reported cash-generation weakness must reverse. The rating's overall framing is a distribution warning rather than an accumulation signal, meaning the weak fundamental and insider pillars outweigh the institutional flow reading. This is an analytical summary of the source data, not personalized financial advice.

Teleflex Incorporated is a NYSE-listed issuer in the Health Care sector, operating in the Medical/Dental Instruments industry. FY 2025 revenue was $1.99B and gross margin was 56.2% per the market data. Business description beyond sector and industry classification: —

Revenue rose from $1.71B in FY 2023 to $1.99B in FY 2025, while net income moved from $357.6M to -$905.6M over the same span. Per the market data, operating margin is 5.9% and net margin is -45.4%, and ROIC is 1.8%. The Altman Z-Score is 2.12, the Piotroski F-Score is 4 out of 9, and Debt/Equity is 0.81. Debt rose from $771.0M in FY 2023 to $2.54B in FY 2025 .

• 🐂 Primary Bull Case: Institutional accumulation and options positioning score 17 of 20, the strongest pillar in the Roarable rating. With Fundamental Cash Engine at 6/20 (ROIC 1.8%, FCF yield -18.00%) and Institutional Whale Flow at 17/20, sustained execution supports upside toward the top of the $100.18 – $145.00 52-week range.
• 🐻 Primary Bear Case: ROIC of 1.8% and FCF yield of -18% leave the fundamental cash engine at 6 of 20 against a forward P/E of 27. Investors must weigh current valuation and 40.9x EV/EBITDA against 5.9% operating margins and a 0.98 macro beta if sector demand softens.

Upstream and downstream dependencies: — Sector correlations beyond the Health Care classification: — Second-order bottlenecks: —

• Key Question #1: What is FCF and EPS for any reported period, given that both are N/A in every financials row?
• Key Question #2: What products and customers generate the $1.99B of FY 2025 revenue?
• Key Question #3: What is the trailing P/E, given the market data reports it as unavailable while EPS is negative?